Access my CV here.

Hayley Thompson NEW Academic headshot Oct 2014I am currently an Associate Professor in the Department of Oncology at Wayne State University School of Medicine and Program Leader of the Population Studies and Disparities Research Program at  Karmanos Cancer Institute, an NCI-designated comprehensive cancer center. My research has primarily focused on the development and testing of culturally targeted interventions at all phases of the cancer care continuum. This includes community-based research implementation, as I am the PI of an AHRQ-funded R01 study examining eHealth activity among diverse cancer survivors in the metro Detroit area as well as the Co-PI of an NHLBI-funded R01 study testing the impact of a culturally targeted colorectal cancer screening navigation intervention among African American men in barbershops and faith-based settings.

In recent years, I’ve expanded my survivorship research. As a PI, I recently completed studies focused on survivorship care planning across two healthcare institutions and the development of a multimedia intervention to increase post-treatment breast cancer surveillance among African American breast cancer survivors.Further, I am the current PI of an American Cancer Society Research Scholar Grant to develop and test a culturally targeted intervention to promote post-treatment surveillance among Latina cancer survivors.

I am also the Director of the Witness Project of Detroit, a community-based outreach and education program to increase breast and cervical cancer screening among African American women and PI of a recently funded study to test a parental decision aid for HPV vaccination in that outreach context.

My team and I have also recently extended our community engagement efforts through Detroit HealthLink for Equity in Cancer Care, funded by a Eugene Washington Community Engagement Award from the Patient-Centered Outcomes Research Institute (PCORI).

My background includes extensive experience in the assessment of sociocultural variables relevant to health outcomes, specifically medical mistrust, and I am the developer of the Group-Based Medical Mistrust Scale, a measure that has been used in a range of disparities research.